116 related articles for article (PubMed ID: 22983001)
1. Cisplatin-induced apoptosis and development of resistance are transcriptionally distinct processes.
Panaretakis T
Cell Cycle; 2012 Oct; 11(20):3723. PubMed ID: 22983001
[No Abstract] [Full Text] [Related]
2. Transcriptional profiling of apoptosis: cell death classification moves toward the systems era.
Yao Z; Szabadkai G
Cell Cycle; 2012 Oct; 11(20):3721-2. PubMed ID: 22982998
[No Abstract] [Full Text] [Related]
3. Independent transcriptional reprogramming and apoptosis induction by cisplatin.
Galluzzi L; Vitale I; Senovilla L; Eisenberg T; Carmona-Gutierrez D; Vacchelli E; Robert T; Ripoche H; Jägemann N; Paccard C; Servant N; Hupé P; Lazar V; Dessen P; Barillot E; Zischka H; Madeo F; Kroemer G
Cell Cycle; 2012 Sep; 11(18):3472-80. PubMed ID: 22918244
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Drp1 Sensitizes Cancer Cells to Cisplatin-Induced Apoptosis through Transcriptional Inhibition of c-FLIP Expression.
Woo SM; Min KJ; Kwon TK
Molecules; 2020 Dec; 25(24):. PubMed ID: 33302576
[TBL] [Abstract][Full Text] [Related]
5. Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated XPC transcription.
Liu Y; Wang X; Li W; Xu Y; Zhuo Y; Li M; He Y; Wang X; Guo Q; Zhao L; Qiang L
Oncogene; 2020 Nov; 39(45):6893-6905. PubMed ID: 32978517
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition.
Cruz-Bermúdez A; Laza-Briviesca R; Vicente-Blanco RJ; García-Grande A; Coronado MJ; Laine-Menéndez S; Palacios-Zambrano S; Moreno-Villa MR; Ruiz-Valdepeñas AM; Lendinez C; Romero A; Franco F; Calvo V; Alfaro C; Acosta PM; Salas C; Garcia JM; Provencio M
Free Radic Biol Med; 2019 May; 135():167-181. PubMed ID: 30880247
[TBL] [Abstract][Full Text] [Related]
7. E2F8 confers cisplatin resistance to ER+ breast cancer cells via transcriptionally activating MASTL.
Tian J; Lin Y; Yu J
Biomed Pharmacother; 2017 Aug; 92():919-926. PubMed ID: 28605876
[TBL] [Abstract][Full Text] [Related]
8. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L
Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of α,β-thujone through metabolic reprogramming and caspase-dependent apoptosis in ovarian cancer cells.
Lee JY; Park H; Lim W; Song G
J Cell Physiol; 2021 Feb; 236(2):1545-1558. PubMed ID: 33000501
[TBL] [Abstract][Full Text] [Related]
10. JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells.
Zanellato I; Colangelo D; Osella D
Curr Cancer Drug Targets; 2018; 18(8):816-828. PubMed ID: 28669341
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
12. A portrait of cisplatin-induced transcriptional changes in mouse embryonic stem cells reveals a dominant p53-like response.
Kruse JJ; Svensson JP; Huigsloot M; Giphart-Gassler M; Schoonen WG; Polman JE; Jean Horbach G; van de Water B; Vrieling H
Mutat Res; 2007 Apr; 617(1-2):58-70. PubMed ID: 17327130
[TBL] [Abstract][Full Text] [Related]
13. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
Lee S; Choi EJ; Jin C; Kim DH
Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
[TBL] [Abstract][Full Text] [Related]
14. Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kim HH; Kwak C
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781788
[TBL] [Abstract][Full Text] [Related]
15. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.
Benedetti G; Fredriksson L; Herpers B; Meerman J; van de Water B; de Graauw M
Biochem Pharmacol; 2013 Jan; 85(2):274-86. PubMed ID: 23103562
[TBL] [Abstract][Full Text] [Related]
16. Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity.
Jiang M; Yi X; Hsu S; Wang CY; Dong Z
Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1140-7. PubMed ID: 15315938
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
[TBL] [Abstract][Full Text] [Related]
18. Molecular barriers to processes of genetic reprogramming and cell transformation.
Chestkov IV; Khomyakova EA; Vasilieva EA; Lagarkova MA; Kiselev SL
Biochemistry (Mosc); 2014 Dec; 79(12):1297-307. PubMed ID: 25716723
[TBL] [Abstract][Full Text] [Related]
19. Cytokine-induced killer cells induce apoptosis and inhibit the Akt/nuclear factor-κB signaling pathway in cisplatin-resistant human glioma U87MG cells.
Cui Y; Yang F; He L
Mol Med Rep; 2015 Nov; 12(5):7027-32. PubMed ID: 26299434
[TBL] [Abstract][Full Text] [Related]
20. Small molecule-induced cellular fate reprogramming: promising road leading to Rome.
Li X; Xu J; Deng H
Curr Opin Genet Dev; 2018 Oct; 52():29-35. PubMed ID: 29857280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
